Evidence map›Paper›PMID 38265800›Full record

ArticleJAMA network open2024

Prevalence, Incidence, and Reversal Pattern of Childhood Stunting From Birth to Age 2 Years in Ethiopia.

Frederick G B Goddard, Bezawit Mesfin Hunegnaw, Jonathan Luu, Sebastien J P A Haneuse, Mesfin Zeleke, Yahya Mohammed, Chalachew Bekele, Daniel Tadesse, Meles Solomon, Delayehu Bekele and 1 more

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Frederick G B GoddardDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Bezawit Mesfin HunegnawDepartment of Pediatrics and Child Health, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Jonathan LuuDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Sebastien J P A HaneuseDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Mesfin ZelekeHaSET, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Yahya MohammedHaSET, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Chalachew BekeleHaSET, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Daniel TadesseHaSET, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Meles SolomonMaternal, Child and Adolescent health lead executive office, Federal Ministry of Health, Ethiopia.
Delayehu BekeleDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Grace J ChanDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Although there has been a reduction in stunting (low-height-for-age and low-length-for-age), a proxy of malnutrition, the prevalence of malnutrition in Ethiopia is still high. Child growth patterns and estimates of stunting are needed to increase awareness and resources to improve the potential for recovery. Objective: To estimate the prevalence, incidence, and reversal of stunting among children aged 0 to 24 months. Design, Setting, and Participants: This population-based cohort study of the Birhan Maternal and Child Health cohort in North Shewa Zone, Amhara, Ethiopia, was conducted between December 2018 and November 2020. Eligible participants included children aged 0 to 24 months who were enrolled during the study period and had their length measured at least once. Data analysis occurred from Month Year to Month Year. Main Outcomes and Measures: The primary outcome of this study was stunting, defined as length-for-age z score (LAZ) at least 2 SDs below the mean. Z scores were also used to determine the prevalence, incidence, and reversal of stunting at each key time point. Growth velocity was determined in centimeters per month between key time points and compared with global World Health Organization (WHO) standards for the same time periods. Heterogeneity was addressed by excluding outliers in sensitivity analyses using modeled growth trajectories for each child. Results: A total of 4354 children were enrolled, out of which 3674 (84.4%; 1786 [48.7%] female) had their length measured at least once and were included in this study. The median population-level length was consistently below WHO growth standards from birth to 2 years of age. The observed prevalence of stunting was highest by 2 years of age at 57.4% (95% CI, 54.8%-9 60.0%). Incidence of stunting increased over time and reached 51.0% (95% CI, 45.3%-56.6%) between ages 12 and 24 months. Reversal was 63.5% (95% CI, 54.8%-71.4%) by age 6 months and 45.2% (95% CI, 36.0%-54.8%) by age 2 years. Growth velocity point estimate differences were slowest compared with WHO standards during the neonatal period (-1.4 cm/month for girls and -1.6 cm/month for boys). There was substantial heterogeneity in anthropometric measurements. Conclusions and Relevance: The evidence from this cohort study highlights a chronically malnourished population with much of the burden associated with growth faltering during the neonatal periods as well as after 6 months of age. To end all forms of malnutrition, growth faltering in populations such as that in young children in Amhara, Ethiopia, needs to be addressed.

Indexed as

Growth DisordersMalnutritionChildChild, PreschoolCohort StudiesEthiopiaFemaleHumansIncidenceInfant, NewbornMalePrevalence

Identifiers

PMID38265800
PMCPMC10809014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.